OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 500 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $173.700 million which missed the analyst consensus estimate of $182.990 million by 5.08 percent. This is a 26.89 percent decrease over sales of $237.600 million the same period last year.
OPKO Health Q1 2024 GAAP EPS $(0.12) Misses $(0.10) Estimate, Sales $173.700M Miss $182.990M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.